TITLE

Neuroimaging of dementia in 2013: what radiologists need to know

AUTHOR(S)
Haller, Sven; Garibotto, Valentina; Kövari, Enikö; Bouras, Constantin; Xekardaki, Aikaterini; Rodriguez, Cristelle; Lazarczyk, Maciej Jakub; Giannakopoulos, Panteleimon; Lovblad, Karl-Olof
PUB. DATE
December 2013
SOURCE
European Radiology;Dec2013, Vol. 23 Issue 12, p3393
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
The structural and functional neuroimaging of dementia have substantially evolved over the last few years. The most common forms of dementia, Alzheimer disease (AD), Lewy body dementia (LBD) and fronto-temporal lobar degeneration (FTLD), have distinct patterns of cortical atrophy and hypometabolism that evolve over time, as reviewed in the first part of this article. The second part discusses unspecific white matter alterations on T2-weighted and fluid-attenuated inversion recovery (FLAIR) images as well as cerebral microbleeds, which often occur during normal aging and may affect cognition. The third part summarises molecular neuroimaging biomarkers recently developed to visualise amyloid deposits, tau protein deposits and neurotransmitter systems. The fourth section reviews the utility of advanced image analysis techniques as predictive biomarkers of cognitive decline in individuals with early symptoms compatible with mild cognitive impairment (MCI). As only about half of MCI cases will progress to clinically overt dementia, whereas the other half remain stable or might even improve, the discrimination of stable versus progressive MCI is of paramount importance for both individual patient treatment and patient selection for clinical trials. The fifth and final part discusses the inter-individual variation in the neurocognitive reserve, which is a potential constraint for all proposed methods. Key Points• Many forms of dementia have spatial atrophy patterns detectable on neuroimaging.• Early treatment of dementia is beneficial, indicating the need for early diagnosis.• Advanced image analysis techniques detect subtle anomalies invisible on radiological evaluation.• Inter-individual variation explains variable cognitive impairment despite the same degree of atrophy.
ACCESSION #
91929824

 

Related Articles

  • On visual hallucinations and cortical networks: a trans-diagnostic review. Carter, Rowena; ffytche, Dominic // Journal of Neurology;Jul2015, Vol. 262 Issue 7, p1780 

    Our current clinical approach to visual hallucinations is largely derived from work carried out by Georges de Morsier in the 1930s. Now, almost a century after his influential papers, we have the research tools to further explore the ideas he put forward. In this review, we address de Morsier's...

  • The common dementias: a pictorial review. Bhogal, Pervinder; Mahoney, Colin; Graeme-Baker, Sophie; Roy, Amit; Shah, Sachit; Fraioli, Francesco; Cowley, Peter; Jäger, Hans Rolf // European Radiology;Dec2013, Vol. 23 Issue 12, p3405 

    Imaging plays an important role in the diagnosis and management of dementia. This review covers the imaging features of the most common dementing illnesses: Alzheimer’s disease (AD), vascular dementia (VaD), dementia with Lewy bodies (DLB) and frontotemporal lobar degeneration (FTLD). It...

  • Parkinsonism, dementia and glucocerebrosidase mutations. Peall, Kathryn; Robertson, Neil // Journal of Neurology;May2013, Vol. 260 Issue 5, p1441 

    The article offers information on several disorders including Parkinsonism, dementia and glucocerebrosidase mutations. Information on influence of glucocerebrosidase mutations on Parkinson's disease in a community-based incident cohort is presented. It further informs about role of...

  • Center for Lewy Body Disease Offers Collaborative Care.  // Journal of Gerontological Nursing;Dec2010, Vol. 36 Issue 12, p29 

    The article discusses a report titled "NYU Langone Establishes Specialty Center for Diagnosis and Treatment of Lewy Body Disease,” located at http:// aging.med.nyu.edu/news/2010/nyu-langoneestablishes-specialty-center-diagnosis-and-treatment-lewy-body-disease.

  • A 63-Year-Old Man with Lewy Body Dementia and Multiple Symptoms. Diaz, Shanna V.; Erickson, Jennifer M.; Abrams, Swala K.; Ralls, Frank M. // Psychiatric Annals;Oct2015, Vol. 45 Issue 10, p493 

    The article presents a case study of a 63-year-old man with Lewy body dementia that was diagnosed seven years before, who was taking dopamine agonists for severe parkinsonism. The patient had obsessive-compulsive behaviors of excessive cleaning. The patient was prescribed the cholinesterase...

  • Fifty Percent Prevalence of extracampine hallucinations in Parkinson's Disease Patients. Wood, Ruth A.; Hopkins, Sarah A.; Moodley, Kuven K.; Chan, Dennis // Frontiers in Neurology;Dec2015, Vol. 6, p1 

    Extracampine hallucinations (EH), the sense of a presence or fleeting movement in the absence of an associated visual percept, have been reported in Parkinson's disease (PD) patients but their prevalence, characteristics, and temporal relationship to visual hallucinations (VH) remain unclear....

  • Can We Propose Rational Clinical Trials for Lewy Body Dementia? Quinn, Joseph // BTG: Future Directions in Neurology;2008, p12 

    The article discusses the pathological, neurochemical, and clinical features of different types of dementia with Lewy bodies (DLB). It states that there is a high level of optimism for treating DLB, however, the standard of care is uncertain and DLB clinical trials have been rare. It reviews...

  • Parkinson's disease dementia and dementia with Lewy bodies -- epidemiology, risk factors and biomarkers. Auning, Eirik; Rongve, Arvid; Aarsland, Dag // Norsk Epidemiologi;2012, Vol. 22 Issue 2, p233 

    Dementia with Lewy bodies (DLB) and Parkinson's disease dementia (PDD) are common and debilitating dementia syndromes accompanied by Parkinsonism and a range of other psychiatric, sleep and autonomic disturbances. Disease mechanisms are unknown, but aggregated Lewy bodies containing...

  • Mild cognitive impairment in Parkinson's disease. Korczyn, Amos // Journal of Neural Transmission;Apr2013, Vol. 120 Issue 4, p517 

    Parkinson's disease (PD) has initially been described as a clinical syndrome, although its exact definition has changed over the past centuries. The identification of the pathological changes added another level of complexity, with Lewy bodies, synuclein deposits and neuronal loss in the...

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics